[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354156-105":59,"doc-detail-354156-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","senescent-stroma-derived-glutamine-a-driver-of-aggressiveness-in-prostate-and-ovarian-cancer-cells","Senescent Stroma-Derived Glutamine - A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells","","Cancer progression depends on tumor-stroma crosstalk, and therapy-induced senescence (TIS) in stromal fibroblasts commonly shapes the tumor microenvironment through SASP. The study defines how senescent stromal metabolism regulates invasion of prostate and ovarian cancer cells. Conditioned media from TIS-induced prostate and ovarian fibroblasts enhance invasion and stem-like traits; metabolomics identifies increased glutamine (Gln) as a heat-stable, extracellular source. Cancer cells increase Gln uptake via SLC1A5 and show EMT and stemness, which are blocked by extracellular Gln depletion, GLS1 inhibition, or fibroblast Gln synthetase silencing. Stromal-derived Gln drives invasion through a redox-dependent NRF2/ETS1 signaling axis, with patient datasets supporting chemotherapy-associated Gln metabolism and ETS1 upregulation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/senescent-stroma-derived-glutamine-a-driver-of-aggressiveness-in-prostate-and-ovarian-cancer-cells/354156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/senescent-stroma-derived-glutamine-a-driver-of-aggressiveness-in-prostate-and-ovarian-cancer-cells/354156.png","ImageObject",300,407,{"name":92,"@type":93},"Chumphorn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does senescent stromal metabolism affect prostate and ovarian cancer invasion?","Question",{"text":113,"@type":114},"Conditioned media from therapy-induced senescent fibroblasts enhances cancer cell invasion. The effect is linked to increased glutamine levels released by senescent stroma and subsequent metabolic uptake by cancer cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does glutamine play in cancer cells exposed to senescent conditioned media?",{"text":118,"@type":114},"Glutamine drives increased invasion along with malignant features including EMT and stemness. Cancer cells adapt by upregulating the transporter SLC1A5 and increasing intracellular Gln.",{"name":120,"@type":111,"acceptedAnswer":121},"How can the invasion-promoting effects of senescent fibroblasts be impaired?",{"text":122,"@type":114},"Extracellular glutamine depletion, pharmacological inhibition of GLS1 in cancer cells, or silencing Gln synthetase in fibroblasts markedly reduces invasion, EMT marker expression, and stemness features.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354156,1790153029,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Article  \nSenescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells  \nGiulia Lori 1,†, Caterina Mancini 1,†, Caterina Paffetti 2, Dayana Desideri 1, Erica Pranzini 2, Alice Santi 2, Manuela Leri 2, Alessio Biagioni 1, Matteo Benelli 2, Pietro Spatafora 3, Fedele Maria Manicone 4, Flavia Sorbi 2, Angela Leo 1, Massimiliano Fambrini 2, Sergio Serni 3, Francesca Magherini 2, * and Maria Letizia Taddei 1, *  \nAcademic Editors: Yongye Huang, Lin Yuan and Yang Yu  \nReceived: 2 March 2026  \nRevised: 22 April 2026  \nAccepted: 23 April 2026  \nPublished: 24 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 50,  \n50134 Florence, Italy; giulia.lori@unifi.it (G.L.); caterina.mancini@unifi.it (C.M.);  \ndayana.desideri@unifi.it (D.D.); alessio.biagioni@unifi.it (A.B.); angela91leo@gmail.com (A.L.)  \n2 Department of Experimental and Clinical Biomedical Sciences—“Mario Serio”, University of Florence, Viale Morgagni 50, 50134 Florence, Italy; caterina.paffetti@unifi.it (C.P.); erica.pranzini@unifi.it (E.P.);  \nalice.santi@unifi.it (A.S.); manuela.leri@unifi.it (M.L.); matteo.benelli@unifi.it (M.B.); flavia.sorbi@unifi.it (F.S.); [massimiliano.fambrini@unifi.it](massimiliano.fambrini@unifi.it) (M.F.)  \n3 Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, Careggi Hospital University of Florence, 50134 Florence, Italy; pietro.spatafora@hotmail.it (P.S.); [sergio.serni@unifi.it](sergio.serni@unifi.it) (S.S.)  \n4 Careggi University Hospital, University of Florence, 50134 Florence, Italy; [fedelemaria.manicone@unifi.it](fedelemaria.manicone@unifi.it)  \n* Correspondence: francesca.magherini@unifi.it (F.M.); marialetizia.taddei@unifi.it (M.L.T.)† These authors contributed equally to this work.  \nHighlights  \nWhat are the main findings?  \n• Therapy-induced senescent fibroblasts secrete high levels of glutamine that enhance prostate and ovarian cancer cell invasion  \n• Stromal-derived glutamine promotes invasion and stem-like features in cancer cells via SLC1A5 upregulation and activation of a redox-dependent NRF2/ETS1 signaling axis.  \nWhat are the implications of the main findings?  \n• Senescent stroma represents a previously unappreciated metabolic source of extracellular glutamine fueling post-therapy tumor aggressiveness.  \n• Targeting glutamine metabolism may counteract therapy-induced pro-tumorigenic microenvironmental effects and reduce relapse risk.  \nAbstract  \nCancer progression is influenced by the dynamic interplay between tumor cells and the surrounding stromal microenvironment. Therapy-induced senescence (TIS) of stromal fibroblasts represents a common outcome of anticancer treatments, contributing to tumor progression through the senescence-associated secretory phenotype (SASP) . While SASP cytokines promote cancer malignancy, the contribution of secreted metabolites from senescent cells remains poorly understood. Here, we investigate the role of senescent stromal metabolism in regulating prostate and ovarian cancer cell invasion. Conditioned media (CM) from TIS-induced human prostate (HPFs) and ovarian fibroblasts (HOFs) promote enhanced invasion of cancer cells. Invasion is partially preserved after exposure to boiled CM, suggesting a role for heat-stable metabolic factors. Metabolomic profiling of senescent fibroblasts-derived CM reveals a significant increase in Glutamine (Gln) levels, identifying senescent stromal fibroblasts as a previously unrecognized source of extracellular Gln in the tumor microenvironment (TME) . Exposure of cancer cells to senescent CM increases Gln  \nuptake, together with upregulation of the transporter SLC1A5 and increased intracellular Gln. This metabolic adaptation is ass","cbCaikLdvroSzZxu","https://ap.wps.com/l/cbCaikLdvroSzZxu","pdf",6578883,"English","# Abstract\n# Introduction\n## Therapy-induced senescence and SASP\n## Study aim and approach","[{\"question\":\"How does senescent stromal metabolism affect prostate and ovarian cancer invasion?\",\"answer\":\"Conditioned media from therapy-induced senescent fibroblasts enhances cancer cell invasion. The effect is linked to increased glutamine levels released by senescent stroma and subsequent metabolic uptake by cancer cells.\"},{\"question\":\"What role does glutamine play in cancer cells exposed to senescent conditioned media?\",\"answer\":\"Glutamine drives increased invasion along with malignant features including EMT and stemness. Cancer cells adapt by upregulating the transporter SLC1A5 and increasing intracellular Gln.\"},{\"question\":\"How can the invasion-promoting effects of senescent fibroblasts be impaired?\",\"answer\":\"Extracellular glutamine depletion, pharmacological inhibition of GLS1 in cancer cells, or silencing Gln synthetase in fibroblasts markedly reduces invasion, EMT marker expression, and stemness features.\"}]","Senescent Stroma-Derived Glutamine - A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells | PDF",1790109272,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ef6ac33ebd1370caf8c0b94aba3d078.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/477e49fe6ee0f68a861d0a7706265f8a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3148765f5136e1fad118e0297a53a2ad.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/311692af9029ae3099dcea71233b49e2.webp",980,1385]